SCOPUS 정보 검색 플랫폼

Journal of Controlled Release

Volumn 79, Issue 1-3, 2002, Pages 7-27

Formulation aspects in the development of osmotically controlled oral drug delivery systems

(3) Verma, Rajan K a Krishna, Divi Murali a Garg, Sanjay a

a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER (India)

Author keywords

Controlled drug delivery; Formulation factors; Osmotic drug delivery; Osmotic pumps; Targeted delivery

Indexed keywords

ACETIC ACID; ACETYLSALICYLIC ACID; CARBAMAZEPINE; CARBOHYDRATE DERIVATIVE; CYCLODEXTRIN; DILTIAZEM; DODECYL SULFATE SODIUM; GLIPIZIDE; HYDROXYETHYLCELLULOSE; HYDROXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; METOPROLOL; MEVINOLIN; NIFEDIPINE; OXPRENOLOL; OXYBUTYNIN; PENTAERYTHRITOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; POLYMER; POLYOX; POTASSIUM CHLORIDE; POVIDONE; RESIN; SALBUTAMOL; SALICYLATE SODIUM; SILICON DIOXIDE; SIMVASTATIN; THEOPHYLLINE; UNINDEXED DRUG;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GASTROINTESTINAL TRACT; HUMAN; OSMOTIC PRESSURE; OSMOTIC PUMP; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; OSMOTIC PRESSURE;

EID: 0037133084 PISSN: 01683659 EISSN: None Source Type: Journal
DOI: 10.1016/S0168-3659(01)00550-8 Document Type: Review

Times cited : (306)

References (84)

1
- 0001885892
- Current status of drug delivery technologies and future directions
- (2001) Pharm. Technol. , vol.25 , pp. 1-14
- Verma, R.K.¹ Garg, S.²

2
- 0022375630
- Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: Design and evaluation of systems for once-daily administration
- (1985) Br. J. Clin. Pharmacol. , vol.19
- Theeuwes, F.¹ Swanson, D.R.² Guittard, G.³ Ayer, A.⁴ Khanna, S.⁵

3
- 0029076668
- Osmotic drug delivery: A review of the patent literature
- (1995) J. Control. Release , vol.35 , pp. 1-21
- Santus, G.¹ Baker, R.W.²

4
- 0034044857
- Osmotically controlled oral drug delivery
- (2000) Drug Dev. Ind. Pharm. , vol.26 , pp. 695-708
- Verma, R.K.¹ Mishra, B.² Garg, S.³

5
- 0016830071
- Elementary osmotic pump
- (1975) J. Pharm. Sci. , vol.64 , pp. 1987-1991
- Theeuwes, F.¹

6
- 85056409200
- Osmotic drug delivery
- A. Kydonieus (Ed.), Marcel Dekker, New York
- (1992) Treatise On Controlled Drug Delivery: Fundamentals, Optimization, Application , pp. 225-253
- Jerzewski, R.L.¹ Chien, Y.W.²

7
- 0008405130
- Osmotic device with dual thermodynamic activity, US patent 4,612,008, Sept. 16, 1986
- Wong, P.S.L.¹ Barclay, B.² Deters, J.C.³ Theeuwes, F.⁴

8
- 0008410328
- Osmotic device with hydrogel driving member, US patent 4,327,725, May 4, 1982
- Cortese, R.¹ Theeuwes, F.²

9
- 0023662119
- Nifedipine gastrointestinal therapeutic system
- (1987) Am. J. Med. , vol.83 , Issue.SUPPL. 6B , pp. 3-9
- Swanson, D.R.¹ Barclay, B.L.² Wong, P.S.L.³ Theeuwes, F.⁴

10
- 0003031804
- Osmotic systems for colon-targeted drug delivery
- P.R. Bieck (Ed.), Marcel Dekker, New York
- (1993) Colonic Drug Absorption and Metabolism , pp. 137-158
- Theeuwes, F.¹ Wong, P.S.L.² Burkoth, T.L.³ Fox, D.A.⁴

11
- 0008405232
- A novel osmotic delivery system: L-OROS Softcap
- Paris (July), CD ROM
- (2000) Proceedings of the International Symposium on Controlled Release of Bioactive Materials
- Dong, L.¹ Shafi, K.² Wan, J.³ Wong, P.⁴

12
- 0008411938
- L-OROS Hardcap: A new osmotic delivery system for controlled release of liquid formulation
- San Diego (June), CD-ROM
- (2001) Proceedings of the International Symposium on Controlled Release of Bioactive Materials
- Dong, L.¹ Wong, P.² Espinal, S.³

13
- 0021887806
- The controlled porosity osmotic pump
- (1985) J. Control. Release , vol.1 , pp. 269-282
- Zentner, G.M.¹ Rork, G.S.² Himmelstein, K.J.³

14
- 0022408524
- Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds
- (1985) J. Control. Release , vol.2 , pp. 217-229
- Zentner, G.M.¹ Rork, G.S.² Himmelstein, K.J.³

15
- 0008322450
- Controlled porosity osmotic pump, US patent 4,968,507, Nov. 6, 1990
- Zentner, G.M.¹ Rork, G.S.² Himmelstein, K.J.³

16
- 0030983431
- A new multiparticulate delayed release system. Part I. Dissolution properties and release mechanism
- (1997) J. Control. Release , vol.47 , pp. 181-189
- Schultz, P.¹ Kleinebudde, P.²

17
- 0030996015
- A new multiparticulate delayed release system. Part II. Coating formulation and properties of free films
- (1997) J. Control. Release , vol.47 , pp. 191-199
- Schultz, P.¹ Tho, I.² Kleinebudde, P.³

18
- 0008367885
- Use of asymmetric membranes in delivery devices, US patent 5,612,059, March 18, 1997
- Cardinal, J.R.¹ Herbig, S.M.² Korsmeyer, R.W.³ Lo, J.⁴ Smith, K.L.⁵ Thombre, A.G.⁶

19
- 0008405233
- Asymmetric membranes in delivery devices, US patent 5,698,220, Dec. 16, 1997
- Cardinal, J.R.¹ Herbig, S.M.² Korsmeyer, R.W.³ Lo, J.⁴ Smith, K.L.⁵ Thombre, A.G.⁶

20
- 0029084991
- Asymmetric-membrane tablet coatings for osmotic drug delivery
- (1995) J. Control. Release , vol.35 , pp. 127-136
- Herbig, S.M.¹ Cardinal, J.R.² Korsmeyer, R.W.³ Smith, K.L.⁴

21
- 0032932451
- Asymmetric membrane capsules for osmotic drug delivery I. Development of a manufacturing process
- (1999) J. Control. Release , vol.57 , pp. 55-64
- Thombre, A.G.¹ Cardinal, J.R.² DeNoto, A.R.³ Herbig, S.M.⁴ Smith, K.L.⁵

22
- 0032899395
- Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance
- (1999) J. Control. Release , vol.57 , pp. 65-73
- Thombre, A.G.¹ Cardinal, J.R.² DeNoto, A.R.³ Gibbes, D.C.⁴

23
- 0034632940
- Nifedipine controlled delivery by sandwiched osmotic tablet system
- (2000) J. Control. Release , vol.68 , pp. 145-156
- Liu, L.¹ Ku, J.² Khang, G.³ Lee, B.⁴ Rhee, J.M.⁵ Lee, H.B.⁶

24
- 0026020623
- The solubility-modulated osmotic pump: In vitro/in vivo release of diltiazem hydrochloride
- (1991) Pharm. Res. , vol.8 , pp. 88-92
- McClelland, G.A.¹ Sutton, S.C.² Engle, K.³ Zentner, G.M.⁴

25
- 0025809463
- Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride
- (1991) J. Control. Release , vol.16 , pp. 237-244
- Zentner, G.M.¹ McClelland, G.A.² Sutton, S.C.³

26
- 0008408103
- Solubility modulated drug delivery system, US patent 4,946,686, Aug. 7, 1990
- McClelland, G.A.¹ Zentner, G.M.²

27
- 0008319847
- Solubility modulated drug delivery device, US patent 4,994,273, Feb. 19, 1991
- Zentner, G.M.¹ McClelland, G.A.²

28
- 0008322453
- Dosage form comprising solubility regulating member, US patent 4,755,180, July 5, 1988
- Ayer, A.D.¹ Wong, P.S.L.²

29
- 0008367887
- Osmotic device that improves delivery properties of agent in situ, US patent 4,326,525, April 27, 1982
- Swanson, D.¹ Edgren, D.²

30
- 0032954546
- Studies on formulation and evaluation of oral osmotic pumps of nimesulide
- (1999) Pharmazie , vol.54 , pp. 74-75
- Verma, R.K.¹ Mishra, B.²

31
- 0008354478
- Composition comprising salbutamol, US patent 4,751,071, June 14, 1988
- Magruder, P.R.¹ Barclay, B.² Wong, P.S.L.³ Theeuwes, F.⁴

32
- 0008359604
- Constant release system with pulsed release, US patent 4,777,049, Oct. 11, 1988
- Magruder, P.R.¹ Barclay, B.² Wong, P.S.L.³ Theeuwes, F.⁴

33
- 0008405132
- Composition comprising a therapeutic agent and a modulating agent, US patent 4,851,229, July 25, 1989
- Magruder, P.R.¹ Barclay, B.² Wong, P.S.L.³ Theeuwes, F.⁴

34
- 0008367581
- Delivery device having encapsulated excipients, US patent 5,697,922, Dec. 16, 1997
- Thombre, A.G.¹

35
- 0032765727
- Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients
- (1999) J. Control. Release , vol.60 , pp. 333-341
- Thombre, A.G.¹ DeNoto, A.R.² Gibbes, D.C.³

36
- 0008329202
- Therapeutic system for sparingly soluble active ingredients, US patent 4,992,278, Feb. 12, 1991
- Khanna, S.C.¹

37
- 0008353824
- Dosage form comprising oxybutynin, US patent 5,840,754, Nov. 24, 1998
- Guittard, G.V.¹ Jao, F.² Marks, S.M.³ Kidney, D.J.⁴ Gumucio, F.⁵

38
- 0008359607
- Oral hypoglycemic glipizide granulation, U.S. patent 5,024,843, June 18, 1991
- Kuczynski, A.L.¹ Ayer, A.D.² Wong, P.S.L.³

39
- 0008403641
- Delivery system for administration blood glucose lowering drug, US patent 5,091,190, Feb. 25, 1992
- Kuczynski, A.L.¹ Ayer, A.D.² Wong, P.S.L.³

40
- 0008319848
- Dosage form for administering oral hypoglycemic glipizide, US patent 5,545,413, Aug. 13, 1996
- Kuczynski, A.L.¹ Ayer, A.D.² Wong, P.S.L.³

41
- 0008367889
- Method for lowering blood glucose, US patent 5,591,454, Jan. 7, 1997
- Kuczynski, A.L.¹ Ayer, A.D.² Wong, P.S.L.³

42
- 0008373180
- Osmotic dispenser with gas generating means, US patent 4,036,228, July 19, 1977
- Theeuwes, F.¹

43
- 0032779325
- 7m-β-CD as both a solubilizing and an osmotic pump agent
- (1999) J. Control. Release , vol.58 , pp. 29-38
- Okimoto, K.¹ Rajewski, R.A.² Stella, V.J.³

44
- 0031662964
- 7m-β-CD
- (1998) Pharm. Res. , vol.15 , pp. 1562-1568
- Okimoto, K.¹ Miyake, M.² Ohnishi, N.³ Rajewski, R.A.⁴ Stella, V.J.⁵ Irie, T.⁶ Uekama, K.⁷

45
- 0032956350
- 7m-β-CD
- (1999) Pharm. Res. , vol.16 , pp. 549-554
- Okimoto, K.¹ Ohike, A.² Ibuki, R.³ Aoki, O.⁴ Ohnishi, N.⁵ Irie, T.⁶ Uekama, K.⁷ Rajewski, R.A.⁸ Stella, V.J.⁹

46
- 0008329204
- Oral osmotic system for slightly soluble active agents, US patent 5,284,662, Feb. 8, 1994
- Koparkar, A.D.¹ Shah, S.B.²

47
- 0008410331
- Dispensing devices powered by lyotropic liquid crystals, US patent 5,108,756, April 28, 1992
- Curatolo, W.J.¹

48
- 0008359608
- Dispensing devices powered by lyotropic liquid crystals, US patent 5,030,452, Jan. 12, 1989
- Curatolo, W.J.¹

49
- 0008393073
- Osmotic drug delivery system, US patent 6,110,498, Aug. 29, 2000
- Rudnic, E.M.¹ Burnside, B.A.² Flanner, H.H.³ Wassink, S.E.⁴ Couch, R.A.⁵ Pinkett, J.E.⁶

50
- 0034601235
- Monolithic osmotic tablet system for nifedipine delivery
- (2000) J. Control. Release , vol.67 , pp. 309-322
- Liu, L.¹ Khang, G.² Rhee, J.M.³ Lee, H.B.⁴

51
- 0020701582
- Elementary osmotic pump for indomethacin
- (1983) J. Pharm. Sci. , vol.72 , pp. 253-258
- Theeuwes, F.¹ Swanson, D.² Wong, P.³ Bonsen, P.⁴ Place, V.⁵ Heimlich, K.⁶ Kwan, K.C.⁷

52
- 0030867080
- Design of a controlled release osmotic pump system of ibuprofen
- (1997) Int. J. Pharm. , vol.158 , pp. 91-97
- Ozdemir, N.¹ Sahin, J.²

53
- 0033973266
- An approach to controlled-release dosage form of propranolol hydrochloride
- (2000) Drug Dev. Ind. Pharm. , vol.26 , pp. 91-94
- Mohammadi-Samani, S.¹ Adrangui, M.² Siahi-Shadbad, M.R.³ Nokhodchi, A.⁴

54
- 0031043933
- Atenolol gastrointestinal therapeutic system: Optimization of formulation variables using response surface methodology
- (1997) J. Control. Release , vol.45 , pp. 121-130
- Sastry, S.V.¹ Reddy, I.K.² Khan, M.A.³

55
- 0031017250
- Atenolol gastrointestinal therapeutic system. I. Screening of formulation variables
- (1997) Drug Dev. Ind. Pharm. , vol.23 , pp. 157-165
- Sastry, S.V.¹ DeGennaro, M.D.² Reddy, I.K.³ Khan, M.A.⁴

56
- 0031770512
- Aqueous-based polymeric dispersion: Face-centered cubic design for the development of atenolol gastrointestinal therapeutic system
- (1998) Pharm. Dev. Tech. , vol.3 , pp. 423-432
- Sastry, S.V.¹ Khan, M.A.²

57
- 0008354480
- Process for forming outlet passageways in pills using a laser, US patent 4,088,864, May 9, 1978
- Theeuwes, F.¹ Saunders, R.J.² Mefford, W.S.³

58
- 0008403644
- Controlled release formulation for water insoluble drugs in which a passageway is formed in situ, US patent 5,736,159, April 7, 1998
- Chen, C.¹ Lee, D.² Xie, J.³

59
- 0008315358
- Method and apparatus for forming a hole in a drug dispensing device, US patent 5,071,607, Dec. 10, 1991
- Ayer, A.D.¹ Balkie, H.H.²

60
- 0008410332
- Process for forming a passageway in an osmotic device, US patent 4,271,113, June 2, 1981
- Luschen, J.G.¹

61
- 0008319849
- Controlled porosity osmotic pump, US patent 4,880,631, Nov. 14, 1989
- Haslam, J.L.¹ Rork, G.S.²

62
- 0025857579
- Use of modified ethyl cellulose lattices for microporous coating of osmotic tablets
- (1991) Pharm. Res. , vol.8 , pp. 600-604
- Appel, L.E.¹ Zentner, G.M.²

63
- 0026600895
- Evaluation of cellulose acetate (CA) latex as coating material for controlled release products
- (1992) Drug Dev. Ind. Pharm. , vol.18 , pp. 519-538
- Kelbert, M.¹ Béchard, S.R.²

64
- 0008329205
- Osmotic devices having composite walls, US patent 4,077,407, March 7, 1978
- Theeuwes, F.¹ Ayer, A.D.²

65
- 0008400557
- Osmotic system having laminar arrangement for programming delivery of active agent, US patent 4,008,719, Feb. 22, 1977
- Theeuwes, F.¹ Ayer, A.D.²

66
- 0008378347
- Osmotic system with instant drug availability, US patent 4,673, 405, June 16, 1987
- Guittard, G.V.¹ Deters, J.C.² Theeuwes, F.³ Cortese, R.⁴

67
- 0008393074
- L.A. Seminoff, G.M. Zentner, Cellulosic coating, US patent 5,126,146, June 30, 1992.

68
- 0029039407
- Variables that affect the mechanism of drug release from osmotic pumps coated with acrylate/methacrylate copolymer latexes
- (1995) J. Pharm. Sci. , vol.84 , pp. 530-533
- Jensen, J.L.¹ Appel, L.E.² Clair, J.H.³ Zentner, G.M.⁴

69
- 0033743431
- Sustained-release tablets via direct compression: A feasibility study using cellulose acetate and cellulose acetate butyrate
- (2000) Pharm. Tech. , vol.24 , pp. 92-106
- Yuan, J.¹ Wu, S.H.²

70
- 0024307316
- Osmotic pumping as a release mechanism for membrane-coated drug formulations
- (1989) Int. J. Pharm. , vol.56 , pp. 261-268
- Lindstedt, B.¹ Ragnarsson, G.² Hjartstam, J.³

71
- 0026088482
- Osmotic pumping release from KCl tablets coated with porous and non porous ethyl cellulose
- (1991) Int. J. Pharm. , vol.67 , pp. 21-27
- Lindstedt, B.¹ Sjorberg, M.² Hjartstam, J.³

72
- 0025670148
- Mechanism of release from pellets coated with an ethylcellulose-based film
- (1990) J. Control. Release , vol.14 , pp. 203-213
- Ozturk, A.G.¹ Ozturk, S.S.² Palsson, B.O.³ Wheatley, T.A.⁴ Dressman, J.B.⁵

73
- 0027318239
- Effects of plasticizers on water permeation and mechanical properties of cellulose acetate: Antiplasticization in slightly plasticized polymer film
- (1993) Drug Dev. Ind. Pharm. , vol.19 , pp. 1541-1555
- Guo, J.¹

74
- 0028279655
- An investigation into the formation of plasticizer channels in plasticized polymer films
- (1994) Drug Dev. Ind. Pharm. , vol.20 , pp. 1883-1893
- Guo, J.¹

75
- 0033407336
- Preparation and characterization of cellulose acetate membrane for monolithic tablet
- (1999) Korea Polym. J. , vol.7 , pp. 289-296
- Liu, L.¹ Khang, G.² Rhee, J.M.³ Lee, H.B.⁴

76
- 0032790307
- 7m-β-CD as both a solubilizer and osmotic agent
- (1999) J. Control. Release , vol.60 , pp. 311-319
- Okimoto, K.¹ Ohike, A.² Ibuki, R.³ Aoki, O.⁴ Ohnishi, N.⁵ Rajewski, R.A.⁶ Stella, V.J.⁷ Irie, T.⁸ Uekama, K.⁹

77
- 0023222320
- Mechanically strong films produced from cellulose acetate latexes
- (1987) J. Pharm. Pharmacol. , vol.39 , pp. 335-338
- Bindschaedler, C.¹ Gurny, R.² Doelker, E.³

78
- 0023278196
- Osmotic water transport through cellulose acetate membranes produced from a latex system
- (1987) J. Pharm. Sci. , vol.76 , pp. 455-460
- Bindschaedler, C.¹ Gurny, R.² Doelker, E.³

79
- 0019495863
- Osmotically actuated dosage forms for rate-controlled drug delivery
- (1981) Pharm. Tech. , vol.5 , pp. 35-44
- Eckenhoff, B.¹ Theeuwes, F.² Urquhart, J.³

80
- 0024802671
- Osmotic delivery of peptides and macromolecules
- (1990) Adv. Drug Deliv. Rev. , vol.4 , pp. 255-276
- Amkraut, A.¹ Eckenhoff, J.B.² Nichols, K.³

81
- 0001088770
- Pumps/osmotic-alzet system
- E. Mathiowitz (Ed.), Wiley, New York
- (1999) Encyclopedia of Controlled Drug Delivery , vol.2 , pp. 900-906
- Perkins, L.¹ Peer, C.² Fleming, V.³

82
- 0000979794
- Pumps/osmotic-VITS veterinary implant
- E. Mathiowitz (Ed.), Wiley, New York
- (1999) Encyclopedia of Controlled Drug Delivery , vol.2 , pp. 906-909
- Magruder, J.¹

83
- 0001276435
- Pumps/osmotic-DUROS osmotic implant for humans
- E. Mathiowitz (Ed.), Wiley, New York
- (1999) Encyclopedia of Controlled Drug Delivery , vol.2 , pp. 909-915
- Wright, J.C.¹ Stevenson, C.L.² Stewart, G.R.³

84
- 0001000894
- Pumps/osmotic-ruminal osmotic bolus
- E. Mathiowitz (Ed.), Wiley, New York
- (1999) Encyclopedia of Controlled Drug Delivery , vol.2 , pp. 915-920
- Wright, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.